Publicacions en col·laboració amb investigadors/es de Wellcome Trust Sanger Institute (9)

2024

  1. An atlas of cells in the human tonsil

    Immunity, Vol. 57, Núm. 2, pp. 379-399.e18

2021

  1. Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study

    Parasites and Vectors, Vol. 14, Núm. 1

  2. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. A distal enhancer at risk locus 11q13.5 promotes suppression of colitis by Treg cells

    Nature, Vol. 583, Núm. 7816, pp. 447-452

2019

  1. Corrigendum: Genetic and Phenotypic Characterization of the Etiological Agent of Canine Orchiepididymitis Smooth Brucella sp. BCCN84.3 (Frontiers in Veterinary Science, (2019), 6, 10.3389/fvets.2019.00175)

    Frontiers in Veterinary Science

  2. Genetic and phenotypic characterization of the etiological agent of canine orchiepididymitis smooth Brucella sp. BCCN84.3

    Frontiers in Veterinary Science, Vol. 6, Núm. JUN

2016

  1. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

    Science Translational Medicine, Vol. 8, Núm. 341

2015

  1. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype

    Leukemia, Vol. 29, Núm. 5, pp. 1177-1185

2014

  1. Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom

    Journal of Virology, Vol. 88, Núm. 22, pp. 13269-13283